Lin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lin Liu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alexander S. Dowdell
Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, USA
1 shared publication - Andrés Vázquez-Torres
Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO, USA
1 shared publication - Calen A. Steiner
Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, USA
1 shared publication - Corey S. Worledge
Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, USA
1 shared publication - Geetha Bhagavatula
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Children’s Hospital Colorado; Mucosal Inflammation Program, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA
1 shared publication - Ian M. Cartwright
Mucosal Inflammation Program and Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, USA
1 shared publication
Latest Publications
- Open Access
- 30 May 2026
- Published by Springer Nature in Microbiome
Metabolic host-microbe crosstalk in stabilization of epithelial HIF
Background: The gastrointestinal tract is home to trillions of microorganisms that interact with their host in profound ways. One mechanism by which these microbes interact with their eukaryotic host is through the establishment of “physiologic hypoxia” in the intestinal mucosa, which has been shown to promote gut barrier function and homeostasis in a hypoxia-inducible factor (HIF)-dependent manner. The association between HIF and intestinal homeostasis has been long understood, as activation of HIF signaling has been shown to promote barrier function both in vitro and in vivo. Although it has been previously established that pathogenic bacteria regulate HIF stabilization and activity in the intestinal epithelium independent of short-chain fatty acid metabolism, it is not clear whether this activity extends to noninfectious and/or commensal bacterial species. Results: Here, we demonstrate that nonpathogenic, commensal strains of Escherichia coli stabilize HIF in intestinal epithelial cells in vitro. Further, we show that HIF is transcriptionally active in epithelia and drives a “pro-barrier” transcriptional program. This property was found to be dependent on bacterial aerobic respiration, as genetic elimination of E. coli aerobic respiration abolished HIF stabilization and the subsequent transcriptional phenotype. Finally, we observed stabilization of tissue HIF-1α in vivo using antibiotic-treated mice colonized with wild-type, but not respiration-deficient, E. coli . Conclusions: These findings demonstrate a novel ability for commensal E. coli to regulate intestinal homeostasis through activation of HIF and suggest that this mechanism might be a major component of the interaction between facultative anaerobes and the intestinal epithelium in the gut. In addition, we hypothesize that consumption of oxygen by enteric bacteria might be leveraged as a novel therapeutic to combat intestinal inflammation, such as that observed during inflammatory bowel disease (IBD).
- 30 May 2026
- Published by Springer Nature in Microbiome
Open AccessMetabolic host-microbe crosstalk in stabilization of epithelial HIF
Background: The gastrointestinal tract is home to trillions of microorganisms that interact with their host in profound ways. One mechanism by which these microbes interact with their eukaryotic host is through the establishment of “physiologic hypoxia” in the intestinal mucosa, which has been shown to promote gut barrier function and homeostasis in a hypoxia-inducible factor (HIF)-dependent manner. The association between HIF and intestinal homeostasis has been long understood, as activation of HIF signaling has been shown to promote barrier function both in vitro and in vivo. Although it has been previously established that pathogenic bacteria regulate HIF stabilization and activity in the intestinal epithelium independent of short-chain fatty acid metabolism, it is not clear whether this activity extends to noninfectious and/or commensal bacterial species. Results: Here, we demonstrate that nonpathogenic, commensal strains of Escherichia coli stabilize HIF in intestinal epithelial cells in vitro. Further, we show that HIF is transcriptionally active in epithelia and drives a “pro-barrier” transcriptional program. This property was found to be dependent on bacterial aerobic respiration, as genetic elimination of E. coli aerobic respiration abolished HIF stabilization and the subsequent transcriptional phenotype. Finally, we observed stabilization of tissue HIF-1α in vivo using antibiotic-treated mice colonized with wild-type, but not respiration-deficient, E. coli . Conclusions: These findings demonstrate a novel ability for commensal E. coli to regulate intestinal homeostasis through activation of HIF and suggest that this mechanism might be a major component of the interaction between facultative anaerobes and the intestinal epithelium in the gut. In addition, we hypothesize that consumption of oxygen by enteric bacteria might be leveraged as a novel therapeutic to combat intestinal inflammation, such as that observed during inflammatory bowel disease (IBD).